Duloxetine, sold under the brand name Cymbalta, is a prescription medication approved to treat five conditions: major depressive disorder, generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. It belongs to a class of drugs called SNRIs, which work on two chemical messengers in the brain simultaneously. This dual action is what makes duloxetine unusually versatile, treating both mental health conditions and certain types of chronic pain.
How Duloxetine Works
Your brain uses chemical messengers called serotonin and norepinephrine to regulate mood, anxiety, and pain signals. Normally, after these chemicals do their job, nerve cells reabsorb them. Duloxetine blocks that reabsorption process, leaving more serotonin and norepinephrine active in the spaces between nerve cells. The result is stronger signaling along the pathways that stabilize mood, reduce anxiety, and dampen pain.
Duloxetine has a stronger effect on serotonin than on norepinephrine, roughly tenfold in terms of binding strength. But the norepinephrine component is what sets it apart from SSRIs (like fluoxetine or sertraline) and gives it a meaningful role in pain management. Blocking norepinephrine reabsorption also indirectly raises levels of dopamine in the prefrontal cortex, the brain region involved in motivation, focus, and decision-making. This happens because norepinephrine transporters in that area also clear dopamine, so blocking them keeps both chemicals active longer.
Depression and Anxiety
Duloxetine is approved as a first-line treatment for major depressive disorder at doses of 40 to 60 mg per day. For generalized anxiety disorder, the typical dose is 60 mg once daily, though some people start at 30 mg for the first week to ease into the medication.
It usually takes 2 to 4 weeks before you notice improvements in mood or anxiety. Some side effects like nausea often show up before the therapeutic benefits do, which can be discouraging early on. This lag time is normal for all antidepressants and reflects how long the brain takes to adapt to changed neurotransmitter levels.
Diabetic Nerve Pain
Nerve damage from diabetes, called diabetic peripheral neuropathy, causes burning, tingling, or stabbing pain in the hands and feet. Duloxetine is one of the few medications specifically approved for this type of pain, prescribed at 60 mg daily.
A Cochrane review of clinical trials found that duloxetine at 60 mg daily produced at least a 50% reduction in pain for a meaningful number of patients, with roughly 1 in 6 people achieving that level of relief who wouldn’t have on a placebo. That may sound modest, but nerve pain is notoriously difficult to treat, and a 50% reduction in pain intensity represents a significant change in daily functioning. Pain relief from duloxetine may take longer to develop than mood improvements, sometimes beyond the initial 4-week window.
Fibromyalgia
Fibromyalgia involves widespread muscle pain, stiffness, and fatigue without a clear structural cause. Duloxetine is one of only three medications approved by the FDA for this condition. The standard dose is 60 mg daily, with a one-week ramp-up starting at 30 mg to reduce the chance of nausea and dizziness.
The benefit for fibromyalgia likely comes from duloxetine’s effect on descending pain pathways, the brain circuits that normally dial down pain signals traveling up from the body. In fibromyalgia, these pathways don’t function properly, so pain signals arrive amplified. By boosting norepinephrine and serotonin activity in these circuits, duloxetine helps restore some of that natural pain-dampening function.
Chronic Musculoskeletal Pain
Beyond fibromyalgia, duloxetine is approved for chronic pain related to muscles and bones, including chronic low back pain and osteoarthritis of the knee. This approval recognizes that long-lasting pain often involves changes in how the nervous system processes pain signals, not just tissue damage at the site. Duloxetine addresses that central component. The dosing mirrors fibromyalgia: 30 mg for one week, then 60 mg daily.
Off-Label Pain Uses
Doctors also prescribe duloxetine for pain conditions beyond its official approvals. One of the better-studied off-label uses is chemotherapy-induced nerve pain. Randomized trials in breast cancer patients receiving taxane-based chemotherapy found duloxetine effective at reducing both the pain and motor symptoms of treatment-related neuropathy. For people dealing with lingering nerve pain after cancer treatment, it is one of the few options with solid clinical evidence behind it.
Common Side Effects
Nausea is the most frequent side effect and the one most likely to cause people to stop taking duloxetine in the first week or two. Dry mouth, drowsiness, fatigue, and constipation are also common. Most of these diminish after the body adjusts, typically within the first few weeks. Starting at a lower dose (30 mg) before moving to the full 60 mg helps reduce the intensity of early side effects.
Duloxetine can also cause dizziness, decreased appetite, and increased sweating. Sexual side effects, including reduced desire and difficulty reaching orgasm, occur in some people and tend to persist for as long as the medication is taken.
Risks by Age Group
Duloxetine carries an FDA black box warning about increased suicidal thoughts and behavior in people under 25. Clinical trial data show 14 additional cases of suicidal thinking per 1,000 patients treated among those under 18, and 5 additional cases per 1,000 among adults aged 18 to 24. For adults 25 to 64, the risk was slightly lower on the medication than on placebo (1 fewer case per 1,000). Adults 65 and older actually showed 6 fewer cases per 1,000 compared to placebo.
This risk is highest in the early weeks of treatment and during dose changes. Close monitoring during these periods is standard practice, especially for younger patients.
Stopping Duloxetine Safely
Duloxetine is well known for causing withdrawal symptoms if stopped abruptly. In pooled data from six clinical trials, 44% of people discontinuing duloxetine experienced withdrawal effects, compared to 23% on placebo. Dizziness is the most common symptom, followed by nausea, headache, irritability, and a pins-and-needles sensation that can come and go throughout the body. Some people report vivid or disturbing dreams. Symptoms typically begin 2 to 4 days after the last dose and can last several weeks.
Gradual tapering over a minimum of four weeks is the standard approach. A typical schedule might step down from 60 mg to 30 mg to 20 mg before stopping entirely, with each step lasting one to two weeks. Even with tapering, some people experience mild withdrawal symptoms, but they’re generally less intense and shorter-lived than with an abrupt stop. This is not a medication to quit cold turkey.